Topin & Associates Has Been Selected by Myriad Genetics, Inc., to Market OnDose(R) Dose Optimization Technology CHICAGO, May 26, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., has selected Topin & Associates (topin.com) to support the ongoing marketing of OnDose Dose Optimization Technology to the oncology...